跳至主要内容
临床试验/NCT04144153
NCT04144153已完成4 期

Opioid Free Total Intravenous Anesthesia Within an Enhanced Recovery After Surgery Pathway for Bariatric Surgery: A Randomized Controlled Clinical Trial

Northwell Health2 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2021年8月9日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
58
试验地点
2
主要终点
Quality of Recovery

研究概览

简要总结

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III
  • Non-pregnant
  • Undergoing laparoscopic bariatric surgery for weight loss.

排除标准

  • Unable to obtain informed consent or consent withdrawn.
  • Patients who are pregnant or nursing.
  • Alcohol or narcotic misuse or dependence in the last 2 years.
  • Preoperative daily opioid use for one year for pain management.
  • Egg or soy product allergy
  • Active liver disease
  • Patients with left ventricular assist devices
  • Abnormal renal function
  • Any contraindication to any opioid or non-opioid pain analgesics
  • Any physical, mental or medical condition that in the opinion of the investigator, makes study participation inadvisable.

结局指标

主要结局

Quality of Recovery

时间窗: Up to two postoperative weeks

Quality of Recovery (QoR-15), a patient-reported outcome questionnaire that assesses the quality of functional recovery after surgery and anesthesia with a minimum score of 0 (very poor recovery) and a maximum score of 150 (excellent recovery).

次要结局

  • Opioid Consumption(Up to postoperative day one)
  • Pain Intensities(Up to postoperative day one)
  • Time to Aldrete Score of 9(Up to postoperative day one)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验